U.S. markets close in 5 hours 44 minutes
  • S&P 500

    4,047.01
    -29.56 (-0.73%)
     
  • Dow 30

    34,180.39
    -214.62 (-0.62%)
     
  • Nasdaq

    11,482.45
    +14.45 (+0.13%)
     
  • Russell 2000

    1,868.63
    -13.04 (-0.69%)
     
  • Crude Oil

    81.73
    +0.51 (+0.63%)
     
  • Gold

    1,797.50
    -17.70 (-0.98%)
     
  • Silver

    22.83
    -0.02 (-0.07%)
     
  • EUR/USD

    1.0476
    -0.0053 (-0.50%)
     
  • 10-Yr Bond

    3.6050
    +0.0760 (+2.15%)
     
  • GBP/USD

    1.2223
    -0.0033 (-0.27%)
     
  • USD/JPY

    135.3630
    +0.0570 (+0.04%)
     
  • BTC-USD

    16,952.10
    -105.39 (-0.62%)
     
  • CMC Crypto 200

    402.25
    +0.83 (+0.21%)
     
  • FTSE 100

    7,568.95
    +10.46 (+0.14%)
     
  • Nikkei 225

    27,777.90
    -448.18 (-1.59%)
     

Why American Well Stock Was Sickly Today

On a decent trading day for most stocks, American Well (NYSE: AMWL) didn't do so well on Wednesday. The healthcare tech solutions provider saw its share price erode by more than 6%, on the back of two analyst moves. The first of these was a price target cut from Piper Sandler's Jessica Tassan, who now feels American Well -- aka Amwell -- is worth $5 per share these days, down from her previous level of $6.